Those experts in Epidemiological modelling are predicting that India’s new case curve will peak around April/May with decline starting around June. (IE Image) By Dr Suresh Singh In my various articles since mid-March on this platform about the present situation, I have advocated three things–vaccine choice including more vaccine brands, vaccination for all ages (above
Health
With the rising demand for mobile healthcare consultations, the future of the m-health market looks bright and full of opportunities By Karan Chopra Telemedicine is the next big opportunity in Indian healthcare. The advances in virtual visits and remote patient monitoring have improved access to quality care by removing traditional barriers such as mobility, distance,
The drug which was originally manufactured to treat the Ebola virus in the year 2014 has been used for other viral outbreaks including SARS and MERS. In addition to several states in the country reporting vaccine shortage, states like Maharashtra, Madhya Pradesh Delhi, Gujarat, and Chhattisgarh have also started reporting a shortage of antiviral drug
(Image Source: Reuters) In a major development, an expert panel has recommended for emergency use of Sputnik V – a COVID-19 vaccine developed by Russia – in India with certain conditions. The final decision will be taken by the Drugs Controller General of India (DCGI). Once approved, it will be rolled in India by Pharma
World Health Organisation/Dr Surya Kant Tripathi. (Image Source: Reuters/Screengrab) The World Health Organisation (WHO) recently recommended that antiparasitic drug Ivermectin must be used to treat COVID-19 patients within the clinical trials only. The WHO sighted lack of conclusive data behind this recommendation, which is applicable to “patients with COVID-19 of any disease severity.” Despite this,